Cresco Labs (CRLBF) Net Income (QoQ) (2020 - 2026)
Cresco Labs (CRLBF) Net Income (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Cresco Labs | 295.09 Mn | 230.98 Mn | 86.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 80.06% |
| Dec 31, 2025 | -288.48% |
| Sep 30, 2025 | -58.12% |
| Jun 30, 2025 | 8.80% |
| Mar 31, 2025 | -368.63% |
| Dec 31, 2024 | 173.71% |
| Sep 30, 2024 | 84.97% |
| Jun 30, 2024 | -2,390.46% |
| Mar 31, 2024 | -109.90% |
| Dec 31, 2023 | 118.31% |
| Sep 30, 2023 | -161.02% |
| Jun 30, 2023 | -56.27% |
| Mar 31, 2023 | 79.10% |
| Dec 31, 2022 | -98.09% |
| Sep 30, 2022 | -220.75% |
| Jun 30, 2022 | 335.04% |
| Mar 31, 2022 | -167.36% |
| Dec 31, 2021 | 116.00% |
| Sep 30, 2021 | -381.62% |
| Jun 30, 2021 | -289.00% |